loratadine has been researched along with prostaglandin d2 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bousquet, J; Chanal, I; Lebel, B; Michel, FB; Morel, A | 1 |
Naclerio, RM | 1 |
De Crescenzo, G; De Paulis, A; Genovese, A; Marone, G; Patella, V; Spadaro, G | 1 |
Berger, U; Günczler, P; Hirschwehr, R; Horak, F; Jäger, S; Marks, B; Schleinzer, K; Stübner, UP; Toth, J | 1 |
Abdelaziz, MM; Devalia, JL; Khair, OA | 1 |
Corren, J; Lemay, M; Lin, Y; Randolph, RK; Rozga, L | 1 |
4 trial(s) available for loratadine and prostaglandin d2
Article | Year |
---|---|
Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.
Topics: Adult; Benzhydryl Compounds; Cyproheptadine; Double-Blind Method; Histamine H1 Antagonists; Histamine Release; Humans; Loratadine; Nasal Provocation Tests; Pollen; Prostaglandin D2; Rhinitis, Allergic, Seasonal; Terfenadine | 1988 |
Effects of antihistamines on inflammatory mediators.
Topics: Cetirizine; Chymases; Histamine H1 Antagonists; Histamine H2 Antagonists; Histamine Release; Humans; Loratadine; Nasal Provocation Tests; Prostaglandin D2; Serine Endopeptidases; Terfenadine; Tryptases | 1993 |
Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.
Topics: Adult; Antigens, Dermatophagoides; Blood Proteins; Bronchial Provocation Tests; Chymases; Cross-Over Studies; Double-Blind Method; Eosinophil Granule Proteins; Eye Diseases; Female; Glycoproteins; Histamine H1 Antagonists; Humans; Inflammation Mediators; Leukotriene C4; Loratadine; Male; Nasal Lavage Fluid; Pilot Projects; Prostaglandin D2; Radioallergosorbent Test; Respiratory Hypersensitivity; Rhinitis; Ribonucleases; Serine Endopeptidases; Skin Tests; Tryptases | 1998 |
Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Bidens; Cinnamomum zeylanicum; Cross-Over Studies; Double-Blind Method; Drugs, Chinese Herbal; Female; Humans; Loratadine; Male; Malpighiaceae; Middle Aged; Nasal Mucosa; Nasal Provocation Tests; Phytotherapy; Pilot Projects; Prostaglandin D2; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2008 |
2 other study(ies) available for loratadine and prostaglandin d2
Article | Year |
---|---|
Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
Topics: Adult; Basophils; Chymases; Histamine H1 Antagonists; Histamine Release; Humans; Leukocytes, Mononuclear; Leukotriene C4; Loratadine; Lung; Prostaglandin D2; Receptors, IgE; Serine Endopeptidases; Skin; Tryptases | 1997 |
The potential of active metabolites of antihistamines in the management of allergic disease.
Topics: Anti-Inflammatory Agents; Butyrophenones; Cells, Cultured; Cetirizine; Chymases; Eosinophils; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity; Intercellular Adhesion Molecule-1; Interleukin-3; Interleukin-8; Loratadine; Mast Cells; Piperidines; Potassium Channel Blockers; Potassium Channels; Prostaglandin D2; Pyridines; Recombinant Fusion Proteins; Recombinant Proteins; Serine Endopeptidases; Terfenadine; Time Factors; Tryptases | 2000 |